High Expectations f...
Health Care: Drugs
Somaxon Pharmaceuticals Inc. (SOMX: NASDAQ)
$0.60 0.01 | 2.41%
02/08/12 - 03:58 PM ET
121.18K / 221.30K
Vol / Avg. Vol:0.60 / 0.58
Open / Prev. Close:0.59 - 0.60
Today's Range:0.42 - 3.26
52 Wk Range:33.33%
Performance YTD:TheStreet Rating:
Portfolios with SOMX
- Portfolio NameUser Type
- ContributorTop 10 Penny Stocks of 2010
- Uservinodkumarn Portfolio 1
- UserSolstock
- UserSUPRATRADE RED-0303102110
- Contributor10 Biotech Stocks Facing FD...
- UserBesV Portfolio 1
- UserMini Dow
- Userblackman37
- Userssm Portfolio 1
- ContributorBarron's Insider Purchases ...
Latest SOMX Headlines from TheStreet
- Transcept Wins Sleeping Pill Approval 11.23.11 | 01:11 pm
- Biotech Stock Mailbag: Somaxon, Transcept 10.07.11 | 06:10 am
- Biotech Stock Mailbag: Generex Bio 06.24.11 | 07:06 am
- Biotech Stock Mailbag: Avanir Pharma 04.01.11 | 07:04 am
- Biotech Stock Mailbag: Cadence Pharma 03.11.11 | 07:03 am
- Biotech Mailbag: BIO CEO Wrap 02.18.11 | 07:02 am
- Clinical Data: Bulls and Bears Round Two 01.25.11 | 06:01 am
- Biotech Stock Mailbag: Aastrom BioSciences 11.23.10 | 08:11 am
- Biotech Sector Weekly Rewind 10.23.10 | 08:10 am
- Biotech Stock Mailbag - Titan Pharma 10.22.10 | 08:10 am
Press Releases for SOMX
- Somaxon Pharmaceuticals Hires Financial Advisor To Assist In Seeking Strategic Alternatives - Business Wire 12.19.11 | 08:12 am
- Somaxon Pharmaceuticals Reports Third Quarter 2011 Financial Results - Business Wire 11.03.11 | 08:11 am
- Somaxon Pharmaceuticals To Report Third Quarter 2011 Results And Conduct Conference Call On Thursday, November 3 - Business Wire 10.19.11 | 04:10 pm
- Somaxon Pharmaceuticals Announces FDA Feedback On Silenor OTC Regulatory Pathway And Changes To Commercial Team - Business Wire 10.03.11 | 04:10 pm
- Somaxon Pharmaceuticals Reports Second Quarter 2011 Financial Results; Company Announces Access To Up To $45 Million In Financing - Business Wire 08.02.11 | 04:08 pm
- Somaxon Pharmaceuticals To Report Second Quarter 2011 Results And Conduct Conference Call On Tuesday, August 2 - Business Wire 07.25.11 | 04:07 pm
- Somaxon And Paladin Announce Silenor® Ex-US Collaboration - Business Wire 06.08.11 | 08:06 am
- Somaxon Pharmaceuticals To Present At The Jefferies 2011 Global Healthcare Conference - Business Wire 05.31.11 | 04:05 pm
- Somaxon Pharmaceuticals Announces Presentation Of Silenor® Data At National Medical Meetings - Business Wire 05.17.11 | 04:05 pm
- Somaxon Pharmaceuticals Reports First Quarter 2011 Financial Results - Business Wire 05.03.11 | 04:05 pm
Partner Headlines for SOMX
- Stocks Off Lows as Fed Paints Bleak Jobs Picture; Factory Orders Top Street - NASDAQ 10.04.11 | 04:10 pm
- Mid-Day Update: Stocks Mixed as Fed Paints Dim Jobs Picture; Greece Default Worries Linger - NASDAQ 10.04.11 | 04:10 pm
- Somaxon Pharmaceuticals Announces FDA Feedback on Silenor OTC Regulatory Pathway and Changes to Commercial Team - Benzinga 10.03.11 | 04:10 pm
- UPDATE: Oppenheimer Downgrades Somaxon Pharmaceuticals to Perform - Benzinga 09.08.11 | 09:09 am
- Future Biotech Superstars - Seeking Alpha 03.30.11 | 09:03 am
- Best Performing Stocks Year to Date - Seeking Alpha 11.01.10 | 09:11 am
- Somaxon Moved Higher On Above Average Volume (SOMX) - Benzinga 08.30.10 | 01:08 pm
- Somaxon Will Do More Than Just Collect Checks in P&G Deal - Seeking Alpha 08.27.10 | 08:08 am
- Somaxon and P&G in Co-Promotion Deal for Insomnia Treatment - Fox Business 08.25.10 | 12:08 pm
- Competitive Technologies: Short Squeeze Coming or Another Leg Down? - Seeking Alpha 08.25.10 | 09:08 am
